CN105886517A - 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 - Google Patents
一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 Download PDFInfo
- Publication number
- CN105886517A CN105886517A CN201610258939.7A CN201610258939A CN105886517A CN 105886517 A CN105886517 A CN 105886517A CN 201610258939 A CN201610258939 A CN 201610258939A CN 105886517 A CN105886517 A CN 105886517A
- Authority
- CN
- China
- Prior art keywords
- ala
- rkmdh1
- malate dehydrogenase
- gly
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010026217 Malate Dehydrogenase Proteins 0.000 title claims abstract description 44
- 238000003259 recombinant expression Methods 0.000 title claims description 9
- 239000013604 expression vector Substances 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 10
- 239000002773 nucleotide Substances 0.000 claims abstract description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 102000013460 Malate Dehydrogenase Human genes 0.000 abstract description 29
- 241000588724 Escherichia coli Species 0.000 abstract description 13
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract description 4
- 239000013598 vector Substances 0.000 abstract description 4
- 239000001630 malic acid Substances 0.000 abstract description 3
- 235000011090 malic acid Nutrition 0.000 abstract description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 241000223252 Rhodotorula Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 19
- 108090000790 Enzymes Proteins 0.000 description 19
- 230000000694 effects Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 241000221523 Rhodotorula toruloides Species 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000007100 Rhodotorula kratochvilovae Species 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 108010044467 Isoenzymes Proteins 0.000 description 2
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 2
- 108010051242 phenylalanylserine Proteins 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- COEXAQSTZUWMRI-STQMWFEESA-N (2s)-1-[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)NCC(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 COEXAQSTZUWMRI-STQMWFEESA-N 0.000 description 1
- BDCLDNALSPBWPQ-UHFFFAOYSA-N 3-oxohexanoic acid Chemical compound CCCC(=O)CC(O)=O BDCLDNALSPBWPQ-UHFFFAOYSA-N 0.000 description 1
- DKJPOZOEBONHFS-ZLUOBGJFSA-N Ala-Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O DKJPOZOEBONHFS-ZLUOBGJFSA-N 0.000 description 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- OMMDTNGURYRDAC-NRPADANISA-N Ala-Glu-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OMMDTNGURYRDAC-NRPADANISA-N 0.000 description 1
- CWEAKSWWKHGTRJ-BQBZGAKWSA-N Ala-Gly-Met Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O CWEAKSWWKHGTRJ-BQBZGAKWSA-N 0.000 description 1
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 1
- IFKQPMZRDQZSHI-GHCJXIJMSA-N Ala-Ile-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O IFKQPMZRDQZSHI-GHCJXIJMSA-N 0.000 description 1
- SDZRIBWEVVRDQI-CIUDSAMLSA-N Ala-Lys-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O SDZRIBWEVVRDQI-CIUDSAMLSA-N 0.000 description 1
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 1
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 1
- DYXOFPBJBAHWFY-JBDRJPRFSA-N Ala-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N DYXOFPBJBAHWFY-JBDRJPRFSA-N 0.000 description 1
- VRTOMXFZHGWHIJ-KZVJFYERSA-N Ala-Thr-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VRTOMXFZHGWHIJ-KZVJFYERSA-N 0.000 description 1
- AENHOIXXHKNIQL-AUTRQRHGSA-N Ala-Tyr-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]([NH3+])C)CC1=CC=C(O)C=C1 AENHOIXXHKNIQL-AUTRQRHGSA-N 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- SWLOHUMCUDRTCL-ZLUOBGJFSA-N Asn-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N SWLOHUMCUDRTCL-ZLUOBGJFSA-N 0.000 description 1
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 1
- BYLSYQASFJJBCL-DCAQKATOSA-N Asn-Pro-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O BYLSYQASFJJBCL-DCAQKATOSA-N 0.000 description 1
- XOQYDFCQPWAMSA-KKHAAJSZSA-N Asn-Val-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOQYDFCQPWAMSA-KKHAAJSZSA-N 0.000 description 1
- XBQSLMACWDXWLJ-GHCJXIJMSA-N Asp-Ala-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XBQSLMACWDXWLJ-GHCJXIJMSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- HKEZZWQWXWGASX-KKUMJFAQSA-N Asp-Leu-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HKEZZWQWXWGASX-KKUMJFAQSA-N 0.000 description 1
- UCHSVZYJKJLPHF-BZSNNMDCSA-N Asp-Phe-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O UCHSVZYJKJLPHF-BZSNNMDCSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000016831 Congenital muscular dystrophy with hyperlaxity Diseases 0.000 description 1
- NQSUTVRXXBGVDQ-LKXGYXEUSA-N Cys-Asn-Thr Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NQSUTVRXXBGVDQ-LKXGYXEUSA-N 0.000 description 1
- AZDQAZRURQMSQD-XPUUQOCRSA-N Cys-Val-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AZDQAZRURQMSQD-XPUUQOCRSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108020004460 Fungal RNA Proteins 0.000 description 1
- ORYMMTRPKVTGSJ-XVKPBYJWSA-N Gln-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O ORYMMTRPKVTGSJ-XVKPBYJWSA-N 0.000 description 1
- AKJRHDMTEJXTPV-ACZMJKKPSA-N Glu-Asn-Ala Chemical compound C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AKJRHDMTEJXTPV-ACZMJKKPSA-N 0.000 description 1
- HPJLZFTUUJKWAJ-JHEQGTHGSA-N Glu-Gly-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HPJLZFTUUJKWAJ-JHEQGTHGSA-N 0.000 description 1
- MFVQGXGQRIXBPK-WDSKDSINSA-N Gly-Ala-Glu Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFVQGXGQRIXBPK-WDSKDSINSA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- ZQIMMEYPEXIYBB-IUCAKERBSA-N Gly-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN ZQIMMEYPEXIYBB-IUCAKERBSA-N 0.000 description 1
- PDAWDNVHMUKWJR-ZETCQYMHSA-N Gly-Gly-His Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 PDAWDNVHMUKWJR-ZETCQYMHSA-N 0.000 description 1
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 1
- VEPBEGNDJYANCF-QWRGUYRKSA-N Gly-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN VEPBEGNDJYANCF-QWRGUYRKSA-N 0.000 description 1
- FFJQHWKSGAWSTJ-BFHQHQDPSA-N Gly-Thr-Ala Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O FFJQHWKSGAWSTJ-BFHQHQDPSA-N 0.000 description 1
- LNJLOZYNZFGJMM-DEQVHRJGSA-N Ile-His-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N LNJLOZYNZFGJMM-DEQVHRJGSA-N 0.000 description 1
- UWLHDGMRWXHFFY-HPCHECBXSA-N Ile-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@@H]1C(=O)O)N UWLHDGMRWXHFFY-HPCHECBXSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 1
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 1
- FOEHRHOBWFQSNW-KATARQTJSA-N Leu-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)N)O FOEHRHOBWFQSNW-KATARQTJSA-N 0.000 description 1
- PBGDOSARRIJMEV-DLOVCJGASA-N Leu-His-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O PBGDOSARRIJMEV-DLOVCJGASA-N 0.000 description 1
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 1
- INCJJHQRZGQLFC-KBPBESRZSA-N Leu-Phe-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O INCJJHQRZGQLFC-KBPBESRZSA-N 0.000 description 1
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 1
- AKVBOOKXVAMKSS-GUBZILKMSA-N Leu-Ser-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O AKVBOOKXVAMKSS-GUBZILKMSA-N 0.000 description 1
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
- GOFJOGXGMPHOGL-DCAQKATOSA-N Leu-Ser-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C GOFJOGXGMPHOGL-DCAQKATOSA-N 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- IOQWIOPSKJOEKI-SRVKXCTJSA-N Lys-Ser-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IOQWIOPSKJOEKI-SRVKXCTJSA-N 0.000 description 1
- 101150058595 MDH gene Proteins 0.000 description 1
- 101100290485 Medicago sativa CMDH gene Proteins 0.000 description 1
- MIAZEQZXAFTCCG-UBHSHLNASA-N Met-Phe-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 MIAZEQZXAFTCCG-UBHSHLNASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-M NAD(1-) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-M 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 1
- QSKCKTUQPICLSO-AVGNSLFASA-N Pro-Arg-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O QSKCKTUQPICLSO-AVGNSLFASA-N 0.000 description 1
- FEVDNIBDCRKMER-IUCAKERBSA-N Pro-Gly-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1 FEVDNIBDCRKMER-IUCAKERBSA-N 0.000 description 1
- AUQGUYPHJSMAKI-CYDGBPFRSA-N Pro-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 AUQGUYPHJSMAKI-CYDGBPFRSA-N 0.000 description 1
- JUJCUYWRJMFJJF-AVGNSLFASA-N Pro-Lys-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1 JUJCUYWRJMFJJF-AVGNSLFASA-N 0.000 description 1
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 1
- SXJOPONICMGFCR-DCAQKATOSA-N Pro-Ser-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O SXJOPONICMGFCR-DCAQKATOSA-N 0.000 description 1
- CHYAYDLYYIJCKY-OSUNSFLBSA-N Pro-Thr-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CHYAYDLYYIJCKY-OSUNSFLBSA-N 0.000 description 1
- ZAUHSLVPDLNTRZ-QXEWZRGKSA-N Pro-Val-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O ZAUHSLVPDLNTRZ-QXEWZRGKSA-N 0.000 description 1
- FHJQROWZEJFZPO-SRVKXCTJSA-N Pro-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FHJQROWZEJFZPO-SRVKXCTJSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- JPIDMRXXNMIVKY-VZFHVOOUSA-N Ser-Ala-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPIDMRXXNMIVKY-VZFHVOOUSA-N 0.000 description 1
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 1
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 1
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 1
- DYEGLQRVMBWQLD-IXOXFDKPSA-N Ser-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CO)N)O DYEGLQRVMBWQLD-IXOXFDKPSA-N 0.000 description 1
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 1
- 206010067130 Spastic diplegia Diseases 0.000 description 1
- GLQFKOVWXPPFTP-VEVYYDQMSA-N Thr-Arg-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GLQFKOVWXPPFTP-VEVYYDQMSA-N 0.000 description 1
- PZVGOVRNGKEFCB-KKHAAJSZSA-N Thr-Asn-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N)O PZVGOVRNGKEFCB-KKHAAJSZSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- NLMXVDDEQFKQQU-CFMVVWHZSA-N Tyr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLMXVDDEQFKQQU-CFMVVWHZSA-N 0.000 description 1
- HSBZWINKRYZCSQ-KKUMJFAQSA-N Tyr-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O HSBZWINKRYZCSQ-KKUMJFAQSA-N 0.000 description 1
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 1
- YFOCMOVJBQDBCE-NRPADANISA-N Val-Ala-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N YFOCMOVJBQDBCE-NRPADANISA-N 0.000 description 1
- ZQGPWORGSNRQLN-NHCYSSNCSA-N Val-Asp-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZQGPWORGSNRQLN-NHCYSSNCSA-N 0.000 description 1
- WFENBJPLZMPVAX-XVKPBYJWSA-N Val-Gly-Glu Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O WFENBJPLZMPVAX-XVKPBYJWSA-N 0.000 description 1
- NHXZRXLFOBFMDM-AVGNSLFASA-N Val-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C NHXZRXLFOBFMDM-AVGNSLFASA-N 0.000 description 1
- KRAHMIJVUPUOTQ-DCAQKATOSA-N Val-Ser-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KRAHMIJVUPUOTQ-DCAQKATOSA-N 0.000 description 1
- LCHZBEUVGAVMKS-RHYQMDGZSA-N Val-Thr-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(O)=O LCHZBEUVGAVMKS-RHYQMDGZSA-N 0.000 description 1
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 1
- NLNCNKIVJPEFBC-DLOVCJGASA-N Val-Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O NLNCNKIVJPEFBC-DLOVCJGASA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 108010009297 diglycyl-histidine Proteins 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 108010054813 diprotin B Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000005868 ontogenesis Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-M oxaloacetate ion Chemical compound OC(=O)C(=O)CC([O-])=O KHPXUQMNIQBQEV-UHFFFAOYSA-M 0.000 description 1
- -1 oxalyl Acetate Chemical compound 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01037—Malate dehydrogenase (1.1.1.37)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种从红冬孢酵母YM25235中分离的编码苹果酸脱氢酶的核苷酸序列,其核苷酸序列如SEQ ID NO:1所示,该基因编码的氨基酸序列如SEQ ID NO:2所示,通过构建重组载体并在大肠杆菌中表达,表达产物具有苹果酸脱氢酶功能,能催化苹果酸转化成草酰乙酸。
Description
技术领域
本发明涉及一种苹果酸脱氢酶基因RKMDH1及其重组表达载体,具体涉及以红冬孢酵母(Rhodosporidium kratochvilovae)YM25235总RNA反转录的cDNA为模板,扩增得到编码苹果酸脱氢酶(MDH)的基因,将其克隆到大肠杆菌表达载体后诱导表达,亲和层析法纯化后得到纯酶,并对该酶进行了酶活测定及酶学性质的相关研究,属于基因工程和酶工程领域。
背景技术
苹果酸脱氢酶( MDH)广泛分布于生物体内,是一种活性非常强的酶,它催化草酰乙酸盐和苹果酸盐的相互转化反应,与二核苷酸辅酶的氧化还原相关。草酰乙酸盐在许多代谢途径中都有重要作用,包括三羧酸循环、乙醛酸旁路、氨基酸合成、糖原异生等,并维持氧化还原平衡,还能促进胞质和亚细胞器代谢物的交换。依生物体的功能不同、组织差异、细胞内定位的不同其表达种类不同,MDH具有多种同工酶形式。胞质苹果酸脱氢酶(cMDH)存在于细胞胞质内,担负着将NADH转入线粒体的重任,并且还对调控三羧酸循环有作用,同时cMDH还是核酸通路(NACh)复合体的一个组成部分。
苹果酸脱氢酶(MDH)广泛分布在动物组织、微生物和植物中。它是一种活性最强的酶,根据亚细胞定位,苹果酸脱氢酶可分为5种类型,存在于乙醛酸体、线粒体、过氧化物体、叶绿体、细胞浆以及锥虫甘油体内。MDH为多聚体酶,是由相同或相似亚基组成的二聚体或四聚体,亚基的分子量为30-35kDa,MDH在医学方面也引起越来越多的关注如利用基因工程疫苗预防人体带绦虫病已是备受关注的研究方向,通过牛带绦虫亚洲亚种MDH基因的生物信息学分析,预测到胞浆型MDH是一个潜在的诊断抗原,这为带绦虫在诊断、药物及疫苗研究中的应用前景提供了重要的线索,在临床诊断中用于多酶分析及疾病的早期诊断,例如用于诊断DIC(弥散性血管内凝血),心肌梗塞,急慢性肝炎等。在食品领域,苹果酸脱氢酶用于有机酸含量的测定,如L-苹杲酸、醋酸、柠檬酸等物质的测定,应用前景广泛。利用MDH底物专一性,还可将其用于拆分D,L-苹果酸酶。总之,MDHs作为生物体中枢代谢途径的关键酶,国内外对其己进行了较为广泛的研究,MDHs同工酶正应用于生物分类、物种分化、遗传变异、物种杂交和个体发育等研究。因此深入了解MDHs的生理生化特性、结构及功能、催化机制,对于酶重组蛋白的表达、纯化及免疫特性分析,探讨生物体中MDHs的代谢作用以及一些疾病的分子致病机制有着重要的意义。同时MDH的应用研究也将会推动MDHs转基因植物及手性药物的进一步发展。
发明内容
本发明的目的是提供一种从红冬孢酵母(Rhodosporidium kratochvilovae)YM25235中分离的苹果酸脱氢酶基因RKMDH1,该基因核苷酸序列如SEQ ID NO:1所示或该核苷酸序列的片段,或与SEQ ID NO:1互补的核苷酸序列,该基因序列长为948bp(碱基),该基因编码的氨基酸序列如SEQ ID NO:2所示的多肽或其片段。
本发明另一目的是提供一种含有所分离的苹果酸脱氢酶基因RKMDH1的重组表达载体,是将SEQ ID NO:1所示基因直接与不同表达载体(质粒、病毒或运载体)连接所构建的重组载体。
本发明另一目的是提供一种含有该苹果酸脱氢酶基因RKMDH1的重组表达载体或上述重组表达载体的宿主细胞大肠杆菌(Escherichia coli)菌株BL21。
用本发明所述的核苷酸序列或含有核苷酸序列的重组载体转化宿主细胞可用本领域的技术人员熟知的方法进行。当宿主为原核生物如大肠杆菌时,用CaCl2、电穿孔等方法进行。当宿主是真核生物,可选用DNA转染法、显微注射、电穿孔、脂质体包装等方法。
本发明提供的核苷酸序列是一种高效、特异性的苹果酸脱氢酶基因,可以将其与载体连接后转化至微生物细胞体内生产苹果酸脱氢酶,具有产物特异性高、生产周期短、生产不受场地、气候、季节的影响及利用不同的菌种和培养基适合开发商业化苹果酸脱氢酶等优点;本发明应用基因工程技术构建特异性生产苹果酸脱氢酶的转基因大肠杆菌生产苹果酸脱氢酶,具有操作简单、成本低、可行性高等优点,为苹果酸脱氢酶基因工程化生产奠定基础。
附图说明
图1为利用本发明的红冬孢酵母YM25235苹果酸脱氢酶基因RKMDH1构建的大肠杆菌重组表达质粒pET32aRKMDH1质粒图谱;
图2为本发明的苹果酸脱氢酶基因RKMDH1诱导表达并纯化后的SDS-PAGE分析图,其中:1为蛋白电泳Marker;2为转化了pET32a(+)并经IPTG诱导的大肠杆菌BL21总蛋白;3为转化了pET32aRKMDH1并经IPTG诱导的大肠杆菌BL21总蛋白;4为纯化的目的蛋白条带。
具体实施方式
下面结合附图和实施例对本发明作进一步详细说明,但本发明保护范围不局限于所述内容,实施例中使用的试剂和方法,如无特殊说明,均采用常规试剂和使用常规方法。
实施例1:红冬孢酵母苹果酸脱氢酶基因RKMDH1的克隆
采用OMEGA试剂盒E.Z.N.A Fungal RNA Kit从红冬孢酵母(Rhodosporidiumkratochvilovae)YM25235中提取总RNA,用反转录试剂盒Thermo Scientific Maxima HMinus First Strand cDNA Synthesis Kit合成cDNA,取1μl为模板进行聚合酶链式反应。设计引物(引物1和引物2)进行PCR 扩增,反应所用引物、组分和扩增条件如下:
引物P1:RKMDHF1: 5`-ATGTTCGCCGCTACTCGCTCCAC-3`(SEQ ID NO:3)
引物P2:RKMDHR1: 5`-CTACGCGTGGAGCTCGCCAAC-3` (SEQ ID NO:4)
PCR扩增体系(50 μL)组成如下:
5×Trans PFU Buffer 10μL
dNTP(2.5μmol/L) 5μL
cDNA 1μL
RKMDHF1(10μmol/L) 2μL
RKMDHR1(10μmol/L) 2μL
Fast Pfu DNA polymerase(5U/μL) 2μL
无菌ddH2O 补足至50μL;
扩增条件:94℃变性4min,再用94℃ 45s、59℃ 45s、72℃ 90s进行30个循环,最后72℃10min,反应完后取产物1μL,然后在浓度为1%的琼脂糖凝胶中,进行电泳分析。经凝胶成像系统成像确认片段大小正确后,用百泰克生物技术有限公司多动能DNA纯化回收试剂盒回收目的片段,然后将PCR扩增得到的目的基因连接到pMD18-T上,连接产物转化大肠杆菌DH5α,用含有氨苄青霉素(Amp+)的LB固体平板进行筛选,挑取平板上的转化子进行菌落PCR筛选阳性克隆,然后送去上海生工测序。测序结果结果显示,获得一段948bp长的序列,命名为RKMDH1,序列组成如SEQ ID NO:1所示的核苷酸序列。
实施例2:重组表达质粒pET32aRKMDH1的构建
采用实施例1中的cDNA为模板进行PCR 扩增,反应所用引物组合、反应组分和扩增条件如下:
引物P3:RKMDHF2: 5`-TACGGATCCATGTTCGCCGCTACTCGCTC-3` (SEQ ID NO:5)
引物P4:RKMDHR2: 5`-CGTCTCGAGCGCGTGGAGCTCGCCAAC-3` (SEQ ID NO:6)
PCR扩增体系(50 µL)组成如下:
5×Fast Pfu Buffer 10μL
dNTP(2.5 µmol/L) 5μL
cDNA 1μL
RKMDHF2(10 µmol/L) 1μL
RKMDHR2(10 µmol/L) 1μL
Fast Pfu DNA polymerase(5U/µL) 1μL
无菌ddH2O 补足至50μL;
扩增条件:94℃变性4min,再用94℃ 45s、64℃ 45s、72℃ 2min进行30个循环,最后72℃ 10min;取纯化的PCR产物和质粒pET-32a分别用BamHⅠ和Hind III酶切过夜,50μl PCR产物反应体系:PCR产物25μL,10×Tango Buffer 10μl,BamHⅠ2μl和Hind III 1.5μL,用灭菌的双蒸水补齐,37℃酶切过夜。50μl质粒pET-32a反应体系:质粒pET-32a 15μl,10×TangoBuffer 10μl,BamHⅠ2μl和Hind III1.5μL,用灭菌的双蒸水补齐,37℃酶切过夜。电泳检验酶切产物,并用凝胶回收试剂盒对酶切产物进行纯化和回收。连接体系(10μL):纯化的PCR产物和表达载体pET-32a 按7:1加样,T4DNA连接酶0.5μL,T4 Buffer 1μL,16℃连接过夜。取连接产物转入大肠杆菌DH5ɑ 中。37℃振荡培养1.5h后,培养液涂布含氨苄的LB培养基平板,37℃培养箱中培养12h,挑取平板上的转化子进行菌落PCR,筛选阳性克隆,构建获得重组表达质粒命名为pET32aRKMDH1,该质粒图谱如图1所示。
实施例3:苹果酸脱氢酶基因RKMDH1在大肠杆菌BL21中的诱导表达
1、苹果酸脱氢酶蛋白RKMDH1的诱导表达及纯化
为了验证该基因编码蛋白的活性,将1μg重组质粒pET32aRKMDH1加入50μL大肠杆菌BL21感受态细胞中,将整个体系冰浴30min之后于42℃热击90s,再次冰浴2min,然后将连接体系吸取并加入至950μL LB液体培养基中,37℃、100rpm振荡孵育1h。孵育结束后于5000rpm离心10 min,留下约80μL 上清液悬浮沉淀后涂布于含有氨苄青霉素(Amp+)的LB固体平板,37℃倒置培养10h。
挑取阳性转化子于100 mL LB(含100μg/mL氨苄霉素)培养基中,37 ℃振荡培养过夜,将富集的菌液按1%比例接种到1L LB液体培养基中,于37℃,160rpm培养至OD600值约为0.8。取5ml菌液作为空白对照,其余加入IPTG至终浓度为1mmol/L,于15℃恒温摇床80rpm诱导培养8小时,12000 rpm离心15min收集菌体。SDS-PAGE分析显示,pET32aRKMDH1转化的大肠杆菌中表达出一条分子量约为50kD的蛋白(见图2泳道3),但在空载体pET32a(+)转化的大肠杆菌中没有(见图2泳道2)。
进一步用该菌体悬浮于适量(使菌悬液的OD600≈20)30 mM的咪唑缓冲液中,冰上超声破碎细胞,4℃、14000 rpm离心15 min。将离心后的上清液用0.2μm的微型滤膜过滤,滤液上样于已用30mM咪唑缓冲液平衡好的His Trap HP柱(1 mL,GE Healthcare),用200mM咪唑缓冲液进行洗脱,洗脱液用离心管按顺序收集,洗脱样品用SDS-PAGE电泳检测,获得一纯蛋白条带(见图2泳道4)。
2、苹果酸脱氢酶RKMDH1的酶活测定
苹果酸脱氢酶是调控苹果酸代谢的关键酶,可以催化苹果酸进行脱氢氧化,伴随着产生草酰乙酸和NADH。由于MDH的酶活在一定的反应时间内与反应产物NADH的浓度变化呈线性关系,所以MDH的活性可通过检测NADH的浓度变化来测定。以苹果酸和NAD(+)为底物加入苹果酸脱氢酶进行反应,用紫外分光光度计在340nm处测定酶活。MDH酶活的的计算:
单位定义:一个酶活力单位是指25℃时每分钟生成1µmolNADH所需的酶量。
苹果酸脱氢酶酶活计算公式:
E=[(Δe/Δt) ×Vt×df]/(ε×D×Vs×C)
=[(0.315-0.236)×1.9×95]/(6.42×1×0.02×0.3482)
=318.93U/mg
Vt-----反应溶液总体积(ml)
ε-----340nm处测定的NADH的吸光度为6.42
D-----光路长(1cm)(比色皿直径)
Vs-----酶液体积(ml)
C-----蛋白质浓度(mg/ml)
Δe/Δt----1min内340nm处吸光度的变化
df----稀释因子
结果显示,所纯化的苹果酸脱氢酶RKMDH1的酶活为318.93 U/mg,表明基因重组载体在大肠杆菌 BL21中诱导表达出来的苹果酸脱氢酶RKMDH1具有苹果酸脱氢酶的活性。
序列表
<110> 昆明理工大学
<120> 一种苹果酸脱氢酶基因RKMDH1及其重组表达载体
<160> 6
<170> PatentIn version 3.5
<210> 1
<211> 948
<212> DNA
<213> 红冬孢酵母
<400> 1
atgttcgccg ctactcgctc caccttttcg aagcgtgcct tctcgacgtc ggcgcgcaac 60
aacacccgcg tcgccgtcct cggcgccgcc ggtggtatcg gccagccgct ctcgctcctc 120
ctcaagctca acccgctcgt ctcgcacctc tcgctgtacg acatccgcct cgccgccggt 180
gtcgccgccg acgtcgacca ctgcaacacc ccgagcaagt gcgtcggcta tggcccggag 240
aacggtggcc tcgagaagtc gctcgagaac gccgacatca tcatcatccc cgctggcatg 300
ccccgcaagc ccggtatgac ccgtgacgac ctcttcaacg cgaacgcgtc gatcgtccgc 360
gacctcgccc aggccgccgc caaggttgcc ccgaaggccc gcatcggcat catcgccaac 420
ccggtcaact cgaccgtccc catcgtcgcc gaggtcttca agaaggccgg cgtctacgac 480
ccgaagcgcc tcttcggtgt caccaccctc gacattgtcc gtgcctcggc cttcctctcg 540
gggattgccg gcaccgcccc caaggacacc aacgtcccgg tcgtcggcgg ccactcgggc 600
ccgaccatcg tcccgctcct ctcgcagctc ccggctggca agaaggttgt cgaggagggc 660
ggcgacaagc tcgctgcgct cgtcaagcgc atccagttcg gcggtgatga ggtcgtcaag 720
gccaaggacg gcgcgggctc ggccaccctc tcgatggctt acgccggtgc cgagttcacc 780
gacgcgatcc tccgcgccat caacggcgag aagaacgtca ccctttgcac ctacgtcgag 840
tcgccgctct acaaggacca gggcgtcgac ttcttctcct cgccggtcac cctctcgtcg 900
gagggcaccg tcgccgagat ccacccggtt ggcgagctcc acgcgtag 948
<210> 2
<211> 315
<212> PRT
<213> 红冬孢酵母
<400> 2
MET Phe Ala Ala Thr Arg Ser Thr Phe Ser Lys Arg Ala Phe Ser Thr Ser Ala Arg Asn
5 15
Asn Thr Arg Val Ala Val Leu Gly Ala Ala Gly Gly Ile Gly Gln Pro Leu Ser Leu Leu
25 35
Leu Lys Leu Asn Pro Leu Val Ser His Leu Ser Leu Tyr Asp Ile Arg Leu Ala Ala Gly
45 55
Val Ala Ala Asp Val Asp His Cys Asn Thr Pro Ser Lys Cys Val Gly Tyr Gly Pro Glu
65 75
Asn Gly Gly Leu Glu Lys Ser Leu Glu Asn Ala Asp Ile Ile Ile Ile Pro Ala Gly MET
85 95
Pro Arg Lys Pro Gly MET Thr Arg Asp Asp Leu Phe Asn Ala Asn Ala Ser Ile Val Arg
105 115
Asp Leu Ala Gln Ala Ala Ala Lys Val Ala Pro Lys Ala Arg Ile Gly Ile Ile Ala Asn
125 135
Pro Val Asn Ser Thr Val Pro Ile Val Ala Glu Val Phe Lys Lys Ala Gly Val Tyr Asp
145 155
Pro Lys Arg Leu Phe Gly Val Thr Thr Leu Asp Ile Val Arg Ala Ser Ala Phe Leu Ser
165 175
Gly Ile Ala Gly Thr Ala Pro Lys Asp Thr Asn Val Pro Val Val Gly Gly His Ser Gly
185 195
Pro Thr Ile Val Pro Leu Leu Ser Gln Leu Pro Ala Gly Lys Lys Val Val Glu Glu Gly
205 215
Gly Asp Lys Leu Ala Ala Leu Val Lys Arg Ile Gln Phe Gly Gly Asp Glu Val Val Lys
225 235
Ala Lys Asp Gly Ala Gly Ser Ala Thr Leu Ser MET Ala Tyr Ala Gly Ala Glu Phe Thr
245 255
Asp Ala Ile Leu Arg Ala Ile Asn Gly Glu Lys Asn Val Thr Leu Cys Thr Tyr Val Glu
265 275
Ser Pro Leu Tyr Lys Asp Gln Gly Val Asp Phe Phe Ser Ser Pro Val Thr Leu Ser Ser
285 295
Glu Gly Thr Val Ala Glu Ile His Pro Val Gly Glu Leu His Ala ***
305 315
<210> 3
<211> 23
<212> DNA
<213> 人工序列
<400> 3
atgttcgccg ctactcgctc cac 23
<210> 4
<211> 21
<212> DNA
<213> 人工序列
<400> 4
ctacgcgtgg agctcgccaa c 21
<210> 5
<211> 29
<212> DNA
<213> 人工序列
<400> 5
tacggatcca tgttcgccgc tactcgctc 29
<210> 6
<211> 27
<212> DNA
<213> 人工序列
<400> 6
cgtctcgagc gcgtggagct cgccaac 27
Claims (2)
1.一种苹果酸脱氢酶基因RKMDH1,其核苷酸序列如SEQ ID NO:1所示,该基因编码的氨基酸序列如SEQ ID NO:2所示。
2.一种含有权利要求1所述苹果酸脱氢酶基因RKMDH1的重组表达载体。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610258939.7A CN105886517B (zh) | 2016-04-25 | 2016-04-25 | 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610258939.7A CN105886517B (zh) | 2016-04-25 | 2016-04-25 | 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105886517A true CN105886517A (zh) | 2016-08-24 |
CN105886517B CN105886517B (zh) | 2019-07-16 |
Family
ID=56704602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610258939.7A Active CN105886517B (zh) | 2016-04-25 | 2016-04-25 | 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105886517B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108753802A (zh) * | 2018-05-22 | 2018-11-06 | 昆明理工大学 | 一个苹果酸脱氢酶基因cimdh1及其重组表达载体 |
CN113061593A (zh) * | 2021-04-02 | 2021-07-02 | 洛阳华荣生物技术有限公司 | 一种l-苹果酸脱氢酶突变体及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104673810A (zh) * | 2015-01-23 | 2015-06-03 | 昆明理工大学 | 一种苹果酸脱氢酶基因mimdh1及其重组表达载体 |
CN105002192A (zh) * | 2015-07-23 | 2015-10-28 | 昆明理工大学 | 一种苹果酸酶基因rkme1及其重组表达载体 |
CN105296509A (zh) * | 2015-11-16 | 2016-02-03 | 昆明理工大学 | 一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 |
-
2016
- 2016-04-25 CN CN201610258939.7A patent/CN105886517B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104673810A (zh) * | 2015-01-23 | 2015-06-03 | 昆明理工大学 | 一种苹果酸脱氢酶基因mimdh1及其重组表达载体 |
CN105002192A (zh) * | 2015-07-23 | 2015-10-28 | 昆明理工大学 | 一种苹果酸酶基因rkme1及其重组表达载体 |
CN105296509A (zh) * | 2015-11-16 | 2016-02-03 | 昆明理工大学 | 一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108753802A (zh) * | 2018-05-22 | 2018-11-06 | 昆明理工大学 | 一个苹果酸脱氢酶基因cimdh1及其重组表达载体 |
CN108753802B (zh) * | 2018-05-22 | 2021-07-16 | 昆明理工大学 | 一个苹果酸脱氢酶基因cimdh1及其重组表达载体 |
CN113061593A (zh) * | 2021-04-02 | 2021-07-02 | 洛阳华荣生物技术有限公司 | 一种l-苹果酸脱氢酶突变体及其应用 |
CN113061593B (zh) * | 2021-04-02 | 2023-11-10 | 洛阳华荣生物技术有限公司 | 一种l-苹果酸脱氢酶突变体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105886517B (zh) | 2019-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104673810B (zh) | 一种苹果酸脱氢酶基因mimdh1及其重组表达载体 | |
CN104673809B (zh) | 一种苹果酸脱氢酶基因及其重组表达载体 | |
US10829755B2 (en) | Genetically engineered arginine deiminase modified by site-directed mutagenesis | |
CN109055327A (zh) | 醛酮还原酶突变体及其应用 | |
CN105296509B (zh) | 一种苹果酸脱氢酶基因rkmdh2及其重组表达载体 | |
CN113087804B (zh) | 一种二价植物免疫融合蛋白及其生产方法和应用 | |
CN104774813B (zh) | 一种亮氨酸脱氢酶及其制备方法和应用 | |
CN105838724B (zh) | 一种苹果酸脱氢酶基因rgmdh1及其重组表达载体 | |
CN107177607A (zh) | 枯草芽孢杆菌bs04的尿酸氧化酶基因及其用途 | |
CN105062992B (zh) | 一种细胞内溶素和编码此细胞内溶素的多核苷酸 | |
CN102776157A (zh) | 改进的酮还原酶多肽、其编码基因以及表达该多肽的细胞 | |
CN109929822A (zh) | 一种米曲霉脂肪酶突变体及其应用 | |
CN105886517B (zh) | 一种苹果酸脱氢酶基因rkmdh1及其重组表达载体 | |
CN103114110A (zh) | 利用固定化酶合成胆红素的方法 | |
CN109913380A (zh) | 生产(-)-α-红没药醇的重组解脂耶氏酵母菌及其构建方法和应用 | |
CN105349557B (zh) | 一种苹果酸酶基因rkme2及其重组表达载体 | |
CN107488639A (zh) | 甲苯单加氧酶及其在手性亚砜生物催化合成中的应用 | |
CN108753802B (zh) | 一个苹果酸脱氢酶基因cimdh1及其重组表达载体 | |
CN109486780A (zh) | 一种催化效率提高的ω-转氨酶突变体 | |
CN106544328A (zh) | 一种亚砜还原酶及其应用和制备方法 | |
CN106636019B (zh) | Sortase A介导的(S)-羰基还原酶寡聚体高效催化(S)-苯基乙二醇的合成 | |
CN104673808B (zh) | 一种苹果酸酶基因及其重组表达载体 | |
CN109337879A (zh) | 一种苹果酸脱氢酶PbMDH及其编码序列和应用 | |
CN109161555A (zh) | 一种海洋低温苹果酸脱氢酶基因及其重组表达载体 | |
CN113801861B (zh) | 一种来源于朝鲜淫羊藿的黄酮4′-o-甲基转移酶及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Qi Inventor after: He Qiang Inventor after: Xiao Hu Inventor after: Ji Xiuling Inventor after: Wei Yunlin Inventor after: Lin Lianbing Inventor before: Zhang Qi Inventor before: Xiao Hu Inventor before: Ji Xiuling Inventor before: Wei Yunlin Inventor before: Lin Lianbing |
|
GR01 | Patent grant | ||
GR01 | Patent grant |